Pharmacokinetics Archives - World Asthma Foundation

December 23, 2016

Study of Safety, Tolerability, and Pharmacokinetics of Multiple Ascending Doses of REGN3500 in Adults With Moderate Asthma

Conditions: Asthma; Moderate Asthma
Interventions: Drug: REGN3500; Drug: Placebo
Sponsors: Regeneron Pharmaceuticals; Sanofi
Not yet recruiting – verified December 2016

View full post on ClinicalTrials.gov: asthma | Studies received in the last 14 days

November 11, 2016

Safety, Tolerability and Pharmacokinetics of Oral Doses of RP3128 (Rhizen Pharmaceuticals 3128)

Conditions: Healthy Volunteers; Asthma
Interventions: Drug: RP3128; Drug: Placebo
Sponsor: Rhizen Pharmaceuticals SA
Recruiting – verified November 2016

View full post on ClinicalTrials.gov: asthma | Studies received in the last 14 days

October 15, 2016

A Study to Assess the Effect of Particle Size of AZD7594 on Pharmacokinetics (PK) After a Single Inhaled Dose When Administered Using the Dry Powder Inhaler in Healthy Volunteers.

Condition: Asthma, Chronic Obstructive Pulmonary Disease (COPD)
Interventions: Drug: Treatment A – AZD7594; Drug: Treatment B – AZD7594; Drug: Treatment C – AZD7594
Sponsor: AstraZeneca
Not yet recruiting – verified October 2016

View full post on ClinicalTrials.gov: asthma | Studies received in the last 14 days

October 12, 2016

A Study to Assess the Effect of Particle Size of AZD7594 on Pharmacokinetics After a Single Inhaled Dose When Administered Using the Dry Powder Inhaler in Healthy Volunteers.

View full post on ClinicalTrials.gov: asthma | Studies received in the last 14 days

January 7, 2016

A Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD7594 Inhaled Formulation in Healthy Japanese Men

Conditions: Asthma; Chronic Obstructive Pulmonary Disease (COPD)
Interventions: Drug: AZD7594 inhalation powder (200 ?g); Drug: AZD7594 inhalation powder (400 ?g); Drug: AZD7594 pressurized inhalation suspension (200 ?g); Drug: AZD7594 placebo inhalation powder; Drug: AZD7594 placebo pressurized inhalation suspension
Sponsor: AstraZeneca
Not yet recruiting – verified December 2015

View full post on ClinicalTrials.gov: asthma | received in the last 14 days

December 26, 2015

A Study of the Safety and Pharmacokinetics of Levodopa Following Administration of CVT 301 (Levodopa Inhalation Powder) in Adults With Asthma

Condition: Asthma
Interventions: Drug: CVT-301 (levodopa inhalation powder); Drug: Carbidopa; Other: Placebo
Sponsor: Acorda Therapeutics
Recruiting – verified December 2015

View full post on ClinicalTrials.gov: asthma | received in the last 14 days

December 17, 2015

Clinical Study to Evaluate Z7200 Pharmacokinetics Profile

Condition: Asthma
Interventions: Drug: Z7200; Drug: Symbicort Turbohaler; Drug: Z7200 with charcoal; Drug: Symbicort Turbohaler with charcoal; Drug: Symbicort Turbohaler replicate
Sponsor: Zambon SpA
Not yet recruiting – verified December 2015

View full post on ClinicalTrials.gov: asthma | received in the last 14 days

August 4, 2015

A Study to Evaluate the Pharmacokinetics of MEDI9929 (AMG 157) in Adolescents With Mild to Moderate Asthma

Condition: Asthma
Intervention: Drug: MEDI9929 (AMG 157)
Sponsors: MedImmune LLC; Amgen
Not yet recruiting – verified July 2015

View full post on ClinicalTrials.gov: asthma | received in the last 14 days

May 9, 2015

Study to Determine the Pharmacokinetics and Tolerability of Fluticasone Propionate MDPI and Fluticasone Propionate/Salmeterol MDPI Compared to High Strength FLOVENT® DISKUS® and ADVAIR® DISKUS® in Patients With Persistent Asthma 12 Years of Age and Older

Condition: Asthma
Interventions: Drug: Treatment A: Fp MDPI; Drug: Treatment B: FS MDPI; Drug: Treatment C Flovent; Drug: Treatment D: Advair
Sponsor: Teva Branded Pharmaceutical Products, R&D Inc.
Not yet recruiting – verified May 2015

View full post on ClinicalTrials.gov: asthma | received in the last 14 days

March 4, 2015